Target intelligence / Profile preview

Mitochondrial Carnitine O-palmitoyltransferase 1A (None)

Target
None
Molecular classification
Enzyme, Transferase
01

Overview

Mitochondrial carnitine O-palmitoyltransferase 1A (CPT1A) is a key enzyme located on the outer mitochondrial membrane. It catalyzes the transfer of long-chain fatty acyl groups from coenzyme A to L-carnitine, forming acylcarnitines. This reaction is essential for transporting long-chain fatty acids into mitochondria for β-oxidation, making CPT1A a rate-limiting step in mitochondrial fatty acid oxidation. CPT1A is predominantly expressed in liver, kidney, pancreas, adipose tissue, lymphocytes, and fibroblasts. It is inhibited by malonyl-CoA, providing tight regulation between lipid synthesis and degradation pathways. Deficiency or dysfunction of CPT1A impairs hepatic ketogenesis and energy production from fats, especially during fasting, and can result in hypoketotic hypoglycemia. Altered expression or localization has been observed in various cancers.

Other names
Carnitine O-palmitoyltransferase 1, liver isoformL-CPT-1CPT1A
02

Mechanism of action

Catalyzes transfer of long-chain acyl groups from Coenzyme A to carnitine, enabling transport of activated fatty acids into mitochondria for β-oxidation. Inhibition by malonyl-CoA regulates lipid synthesis and degradation.

03

Biological functions

Fatty acid transportBeta-oxidationLipid metabolismEnergy homeostasisKetogenesis
04

Disease associations

Metabolic syndromeCardiovascular diseaseType II diabetesSystemic primary carnitine deficiencyCancer
05

Safety considerations

Hypoketotic hypoglycemia due to impaired hepatic ketogenesis and energy production from fats

Beyond the preview

Go deeper on Mitochondrial Carnitine O-palmitoyltransferase 1A (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial Carnitine O-palmitoyltransferase 1A (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call